- Filed
- Oct 5, 2026
- Last modified
- Oct 27, 2026
- Petitioner
- BMJ Publishing Group Limited
- Inventor
- Carl BATE et al
Invalidity dossier
US 12518883
Translation of medical evidence into computational evidence and applications thereof
Owner recorded by Google Patents: Evidium IncSource retrieved 11/6/2026. Recorded ownership may lag transfers.
Added 10/6/2026, 4:00:07 AM
Ownership records and AI summaries may refer to different dates or entities. An asserting party is not proof of current ownership. Check the recorded ownership history and source dates before relying on a claim.
Patent summary
Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.
AI-generated interpretation, not a determination of patent validity. Check the cited records before relying on it.
Patent Overview: US 12518883 B2
Title: Translation of medical evidence into computational evidence and applications thereof
Assignee: Evidium Inc (original assignee; assignment recorded 2025-02-25 to EVIDIUM, INC.)
Key dates (as listed on the source page): Priority date 2022-04-15; filing date 2025-02-11 (application US19/050,872); publication of US20250191783A1 on 2025-06-12; patent granted and published as US12518883B2 on 2026-01-06. Anticipated expiration listed as 2043-04-14. Legal status listed as Active (the page notes legal status is an assumption, not a legal conclusion).
Inventors: Carl Bate, Wian Stipp, Thomas Unger, David A. Epstein, Matthew McSorley, Fady Nakhla, David Robinson, Jennifer May Lee, Arthur Böök.
Purpose and plain-language scope: The patent concerns making medical evidence "computational." According to the supplied text, medical evidence today is predominantly narrative and document-based, causing delay, ineffective scaling, alert fatigue, and minimal feedback. The described platform extracts medical evidence or related clinical guidelines from any source and places it into a structured, computational representation usable by any application to query the evidence and map it to external data inputs such as a patient chart.
A database of interlinked computational elements—conditions, diagnostic factors, risk factors, and investigations—is described as usable across applications including clinical decision support, diagnosis, administrative processes (e.g., prior authorization, scheduling), and research. Embodiments are described as: (1) representing clinical concepts as elemental factors and investigations that are computationally useful and shared across conditions; (2) determining a patient's clinical state using those elements; and (3) determining a next-best action for that patient. The text also describes a diagnostic glass interface and a next-best-action (NBA) engine operating with a graph database, NLP, and classification. Figure listings include FIGS. 1–6 and FIG. 10 (example transformation of evidence-based text to computational data).
What the excerpt does not establish: It does not provide claim language or claim scope, the full specification, detailed description, or drawings. It does not establish validity, enforceability, inventorship determinations, or the accuracy of listed assignees/dates beyond the source page's own caveats. No litigation, ownership-transfer, or prior-art analysis is included here.
Generated 10/7/2026, 12:00:49 AM
Cases on file (0)
Specific litigation cases in our database that name US patent 12518883. The free-form analysis below may also discuss cases beyond this list.
No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Proceedings on file (1)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Assignment history
Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.
Prior art
Earlier patents, publications, and products that may anticipate or render the claims unpatentable.
Obviousness
Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
Derivative works
Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.